"And we're not used to having somebody without a career at stake in the room at a senior level," said Hudson.

Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its ...

XtalPi Holdings, an artificial intelligence (AI) drug discovery firm based in the Greater Bay Area, is changing the ...

Cebranopadol, a dual-NMR agonist, reached the primary endpoint in a Phase III trial and matched placebo for safety, a ...

For the uninitiated, Recursion wants to become the go-to provider of AI-based drug discovery and development services for the ...

In this edition of “Rising High,” The Fly conducted an exclusive interview with Erez Aminov, Chairman & Chief Executive Officer of MIRA ...

JW Pharmaceutical gains approval for immune thrombocytopenia treatment Tavalisse JW Pharmaceutical receives green light for ...